Health,
“why they approved Redemsivir and Not Other therapies that work better?”
ClinicalTrials. gov Identifier: NCT04280705
Initial trial indicating a quicker recovery for those with Redemsivir, the data was significant which is probably why they approved it.
Other therapies, what are you referring to?
Take a look at https://doi. org/10.7326/M20-4207
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
A Randomized Trial
Conclusion:
Hydroxychloroquine did not substantially reduce symptom severity in outpatients with early, mild COVID-19.
thank you!